SBIR/STTR Research Award

Compact Liquid Chromatography for Routine Screening in Drug Treatment Centers

Award identifier 2f94026d7d2fac7a932776c3307d1808797a07314ac1cea418062c41ed5f0228Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$313,624

Program and phase

SBIR · Phase I

Award year

2022

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
AXCEND LLC
Proposal award date
2022-09-30
Contract end date
2024-04-30
UEI
N4E6BE7KDKM1
Solicitation number
PAR22-073
Topic code
NIDA

Research abstract

Project Summary The overall technical goal of the predicate Phase I project is to adapt a compact, simple-to-operate capillary liquid chromatography (LC) platform based on Axcend’s compact Focus LC for near real-time sensitive and accurate screening of patients for drugs of abuse (DOA) usage, which would deliver essential analytical information to clinicians in point-of-care (POC) facilities (i.e., pain clinics and drug treatment centers) immediately after patient urine samples are taken. The goal is to provide much more timely and effective treatment to patients undergoing drug rehabilitation compared to the current alternatives characterized by sophisticated technology, inadequate specificity, and/or long turn-around time. This will be accomplished by modifying the LC platform and developing simple, automated, robust sample preparation workflows and devices. This development will address a critical need in the healthcare industry for patients requiring treatment for abuse drug use. The overall business goal of our predicate Phase I project and, therefore, the motivation behind our proposed participation in the I- Corps program, is to identify the best potential markets for the main product of Axcend, i.e., the Axcend Focus LC, and to provide ideas to best market the instrument to businesses involved in DOA treatment. From I-Corps instructor suggestions and the many interviews that will be conducted, we expect to identify the most fruitful markets to address as well as specific modifications to the product that can be made at this stage of its development to make it more suitable and attractive to the various markets. The I-Corps team and company in general understand the value of the I-Corps program. We believe that participation in I-Corps is extremely valuable, if not essential, for us to reach the marketing goals desired by us and expected by the SBIR grant program. Financial support from the I-Corps program would greatly assist us in fulfilling the commitments of participation. The I-Corps team members understand the commitment required to participate in this cohort and are prepared to immerse themselves in the program.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

4 SBIR/STTR records share this UEI (2018–2022). Reported award amounts total $2,175,263. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.